PCI Pharma Services, a contract development and manufacturing organization (CDMO) has announced a 60% expansion of temperature-controlled storage space, from the equivalent of 800 pallet spaces to over 1,300. That 2-8°C storage is primarily to […]
They have signed a licence agreement with Archer Daniels Midland Company (NYSE: ADM) to provide catalyst and process technology for catalytic production of bio-based glucaric acid. The licensed process, jointly developed between Johnson Matthey and […]
CureFilm is the next generation market alternative to traditional tablets, capsules, chewables, injections and liquids when delivering active pharmeceutical ingredients. It’s designed for oral administration, and dissolves to release active ingredients to the bloodstream enterically, […]
A new and innovative annual gathering of commercial and operational executives from the pharmaceutical and healthcare industries who are dedicated to achieving regulatory compliance and shaping the future of digital drug supply with information sharing […]
Based on positive results from Cellceutix’s Phase 1 trial of Kevetrin in solid tumors conducted at Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center, the Company is moving forward with a Phase 2 trial […]